Cash Runway: As of June 30, 2025, ARS Pharma had cash, cash equivalents, and short-term investments of $240.1 million, with 98,697,658 shares of common stock outstanding. The company reiterates its ...

A NASA study finds sinus and nasal issues affect 85 percent of astronauts in space, with spacewalks making symptoms worse.